Literature DB >> 31308825

Trends of basal cell carcinoma at the Centre of Dermatovenereology of Vilnius University.

Ramunė Jurčiukonytė1,2,3, Domantas Stundys1,2, Iveta Gylienė1,2, Jūratė Grigaitienė1,2, Matilda Bylaitė-Bučinskienė2,3.   

Abstract

INTRODUCTION AND
OBJECTIVES: Basal cell carcinoma is the most common locally invasive malignant epidermal neoplasm in humans and its incidence has increased over the last decades worldwide, especially among the Caucasian population. Basal cell carcinoma accounts for about 75% of all skin cancers. Incidence data on basal cell carcinoma is sparse because traditional cancer registries often do not register these tumours. In Lithuania, patients with skin cancer and melanoma were traditionally treated in centralized oncological institutes. From 2006, the Centre of Dermatovenereology at Vilnius University Hospital Santaros Klinikos (Vilnius, Lithuania) provides modern diagnostic and treatment facilities to oncodermatological patients. The objective of the study was to evaluate epidemiological and clinical data of basal cell carcinoma at the Centre of Dermatovenereology during the last 15 years.
MATERIALS AND METHODS: Medical documentation of the cases of histologically-proven basal cell carcinoma diagnosed between 2000 and 2015 was analyzed. Epidemiological and clinical evaluation according to the patients' age, sex, and place of residence, as well as tumour localization, its histological type, and treatment options was performed.
RESULTS: After the skin lesion biopsy and histopathological examination, a total of 847 basal cell carcinomas were confirmed to 782 patients. During the study period, the total annual number of newly diagnosed basal cell carcinomas rose steadily in our centre: 2.7% between 2000 and 2003, 6.5% between 2004 and 2006, 13.6% between 2007 and 2009, 27.6% between 2010 and 2012, and 49.6% between 2013 and 2015. The biggest part of patients (28.4%) were 70-79 years old, 4.6% - younger than 40, 7.3% - 40-49, 17.1% - 50-59, 27.2% - 60-69, 14.1% - 80-89, and 1.3% ≥90 years old. The average patient age was 66.0 (±13.6). Of these patients, 62.0% were female and 38.0% male; 63.6% were from the capital city, 18.3% from other cities, and 18.2% from rural areas. Basal cell carcinomas occurred most often in the face region 49.0%, followed by the trunk - 29.4%, the scalp and neck - 10.9%, arms and legs - 7.7%, in 2.9% location was not specified and the whole body - 0.1%. The predominant histological type of basal cell carcinomas was nodular (60.6%), other diagnosed types were superficial (22.9%), infiltrative/morpheaform (8.0%), mixed nodular and infiltrative (1.7%), pigmented (0.2%), rare types (micronodular, infundibulocystic, ductal and mixed) - 0.6%; the type was not specified in 6.0% of cases. Nodular, superficial, and infiltrative types were the most common morphological types in all body sites: respectively, in the face - 67.5%, 12.5%, 9.4%; in the scalp and neck region - 77.2%, 14.1%, 5.4%; in the trunk - 49.8%, 37.3%, 7.2%; in extremities - 41.5%, 43.1%, 7.7%. The nodular type was more common among the elderly and its incidence increased with age (p = 0.009), meanwhile, superficial basal cell carcinomas prevailed among younger patients (<40 years), and its incidence decreased with age (p < 0.001). Also, the nodular type was usually found in the areas of the face (p < 0.001) and the scalp and neck (p = 0.045), and the superficial type - in the areas of the trunk (p < 0.001) and extremities, specifically in the hand (p = 0.022). Basal cell carcinomas were mostly treated with surgical excision (79.6%), photodynamic therapy (5.5%; in our centre, this treatment option is available from 2007), and other/combined methods (14.9%).
CONCLUSIONS: The results showed that the number of newly diagnosed basal cell carcinomas increased continuously between 2000 and 2015. Basal cell carcinomas in our centre occurred most often among the patients aged 70-79 years. This tumour was more often diagnosed in female than male patients. Most of basal cell carcinomas were located on the chronically sun-exposed skin, such as the face region, and were of the nodular histological type, which is more common among the elderly, while the superficial type is more prevalent among younger patients. The most commonly used treatment option for basal cell carcinoma was surgical excision. Acknowledgment of the tendency of the rising number of basal cell carcinomas, healthcare resources, highlights the need for an effective skin cancer prevention strategy in Lithuania.

Entities:  

Keywords:  Lithuania; basal; cancer; carcinoma; cell; epidemiology; epidermal; histopathology; neoplasm; oncodermatology; skin

Year:  2018        PMID: 31308825      PMCID: PMC6591691          DOI: 10.6001/actamedica.v25i4.3930

Source DB:  PubMed          Journal:  Acta Med Litu        ISSN: 1392-0138


  20 in total

1.  Indoor ultraviolet tanning: what the data do and do not show regarding risk of melanoma and keratinocyte malignancies.

Authors:  Martin A Weinstock; David E Fisher
Journal:  J Natl Compr Canc Netw       Date:  2010-08       Impact factor: 11.908

2.  Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians.

Authors:  Hongmei Nan; Peter Kraft; David J Hunter; Jiali Han
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

Review 3.  Guidelines for the management of basal cell carcinoma.

Authors:  N R Telfer; G B Colver; C A Morton
Journal:  Br J Dermatol       Date:  2008-07       Impact factor: 9.302

Review 4.  Hereditary tumour syndromes featuring basal cell carcinomas.

Authors:  L J M T Parren; J Frank
Journal:  Br J Dermatol       Date:  2011-06-03       Impact factor: 9.302

5.  Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995.

Authors:  A Hannuksela-Svahn; E Pukkala; J Karvonen
Journal:  Arch Dermatol       Date:  1999-07

Review 6.  Basal cell carcinoma: what's new under the sun.

Authors:  Clio Dessinioti; Christina Antoniou; Andreas Katsambas; Alexander J Stratigos
Journal:  Photochem Photobiol       Date:  2010 May-Jun       Impact factor: 3.421

7.  Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population.

Authors:  Alain A Demers; Zoann Nugent; Catalin Mihalcioiu; Marni C Wiseman; Erich V Kliewer
Journal:  J Am Acad Dermatol       Date:  2005-08       Impact factor: 11.527

Review 8.  The epidemiology of skin cancer.

Authors:  Thomas L Diepgen; V Mahler
Journal:  Br J Dermatol       Date:  2002-04       Impact factor: 9.302

Review 9.  Epidemiology and aetiology of basal cell carcinoma.

Authors:  J Roewert-Huber; B Lange-Asschenfeldt; E Stockfleth; H Kerl
Journal:  Br J Dermatol       Date:  2007-12       Impact factor: 9.302

Review 10.  Cutaneous ultraviolet exposure and its relationship to the development of skin cancer.

Authors:  Darrell S Rigel
Journal:  J Am Acad Dermatol       Date:  2008-05       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.